News That Matters

Tag: NYSE:HIMS

Hims & Hers Health, Inc. (NYSE:HIMS) Receives Average Rating of “Moderate Buy” from Brokerages
Health

Hims & Hers Health, Inc. (NYSE:HIMS) Receives Average Rating of “Moderate Buy” from Brokerages

Hims & Hers Health, Inc. (NYSE:HIMS - Get Rating) has been given an average recommendation of "Moderate Buy" by the eight brokerages that are covering the firm, MarketBeat Ratings reports. One investment analyst has rated the stock with a hold rating and three have issued a buy rating on the company. The average twelve-month price target among brokerages that have issued ratings on the stock in the last year is $8.06. A number of research analysts have recently weighed in on HIMS shares. SVB Leerink upgraded Hims & Hers Health from a "market perform" rating to an "outperform" rating and set a $5.00 price target for the company in a research report on Tuesday, November 8th. Piper Sandler increased their price target on shares of Hims & Hers Health from $6.00 to $7.00 in a re...